2026 Q3 Portfolio Activity
In 2026 Q3, Sands Capital Alternatives, LLC maintained a portfolio of 25 distinct positions. The most significant new addition was FREENOME INC, now representing 2.73% of the total fund value. They heavily accumulated shares in CEREBRAS SYSTEMS INC, increasing the position by 273.1%. The fund also reduced its exposure to DATADOG INC by 22.1%.
Position History
hover any row below to update
Loading…
Total Positions
25
Quarter
2026 Q3
Top Holding
ALMR (20.7%)
Top 10 Concentration
81.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-25 of 25
Sands Capital Alternatives, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALMR
ALAMAR BIOSCIEN...
|
Healthcare | 20.75% | 18.68% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
4,230,926 | $144,147,649 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NU
NU HLDGS LTD
|
Financial Services | 12.74% | 15.45% |
#2
Prev: #2
|
6.0 |
—
|
-103,018 | -1.5% |
P
S
|
6,991,934 | $88,517,884 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 10.92% | 9.47% |
#3
1
Prev: #4
|
7.0 |
—
|
289,855 | 7.8% |
P
S
|
3,997,898 | $75,880,104 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
SPYGLASS PHARMA...
|
|
Unknown | 9.36% | 9.07% |
#4
1
Prev: #5
|
5.2 |
—
|
no change | no change |
P
S
|
2,500,012 | $65,000,312 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
KVYO
KLAVIYO INC
|
Technology | 8.67% | 9.67% |
#5
2
Prev: #3
|
4.5 |
—
|
-100,787 | -2.6% |
P
S
|
3,827,359 | $60,204,357 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 6.27% | 3.01% |
#6
5
Prev: #11
|
3.5 |
—
|
no change | no change |
P
S
|
481,770 | $43,532,737 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 3.86% | 4.31% |
#7
1
Prev: #6
|
2.5 |
—
|
no change | no change |
P
S
|
13,018,965 | $26,819,068 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CBRS
CEREBRAS SYSTEM...
|
Technology | 3.13% | 1.18% |
#8
9
Prev: #17
|
4.3 |
—
|
89,659 | 273.1% |
P
S
|
122,484 | $21,759,283 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DASH
DOORDASH INC
|
Consumer Cyclical | 2.84% | 3.84% |
#9
2
Prev: #7
|
1.6 |
—
|
-20,261 | -15.9% |
P
S
|
107,301 | $19,695,099 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ODTX
ODYSSEY THERAPE...
|
Healthcare | 2.80% | 2.67% |
#10
3
Prev: #13
|
2.1 |
—
|
no change | no change |
P
S
|
875,000 | $19,442,500 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FRNM
FREENOME INC
|
Healthcare | 2.73% | — |
#11
Prev: #—
|
4.6 |
—
|
1,201,998 | — |
NEW
|
1,201,998 | $18,931,469 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CPNG
COUPANG INC
|
Consumer Cyclical | 2.48% | 3.76% |
#12
4
Prev: #8
|
1.5 |
—
|
-84,905 | -6.4% |
P
S
|
1,244,409 | $17,259,953 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DDOG
DATADOG INC
|
Technology | 2.48% | 3.43% |
#13
4
Prev: #9
|
1.0 |
—
|
-17,831 | -22.1% |
P
S
|
63,020 | $17,258,027 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IOT
SAMSARA INC
|
Technology | 2.17% | 2.73% |
#14
2
Prev: #12
|
0.9 |
—
|
-120,037 | -23.3% |
P
S
|
395,621 | $15,085,029 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TOST
TOAST INC
|
Technology | 1.31% | 1.65% |
#15
1
Prev: #14
|
1.0 |
—
|
-49,972 | -13.7% |
P
S
|
314,907 | $9,129,154 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ABOS
ACUMEN PHARMACE...
|
Healthcare | 1.19% | 1.62% |
#16
1
Prev: #15
|
1.5 |
—
|
no change | no change |
P
S
|
3,720,105 | $8,258,633 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SNOW
SNOWFLAKE INC
|
Technology | 1.12% | 1.02% |
#17
1
Prev: #18
|
0.9 |
—
|
-1,572 | -6.4% |
P
S
|
22,926 | $7,784,753 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.96% | 0.87% |
#18
2
Prev: #20
|
1.4 |
—
|
no change | no change |
P
S
|
85,000 | $6,681,850 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TTAN
SERVICETITAN IN...
|
Technology | 0.86% | 1.25% |
#19
3
Prev: #16
|
0.8 |
—
|
-17,444 | -16.1% |
P
S
|
91,101 | $5,993,535 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 0.80% | 3.14% |
#20
10
Prev: #10
|
1.3 |
—
|
no change | no change |
P
S
|
786,353 | $5,575,243 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MNDY
MONDAY COM LTD
|
Technology | 0.76% | 0.97% |
#21
2
Prev: #19
|
0.8 |
—
|
-14,800 | -18.1% |
P
S
|
67,182 | $5,271,100 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ACRV
ACRIVON THERAPE...
|
Healthcare | 0.68% | 0.66% |
#22
1
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
2,289,271 | $4,693,006 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CADL
CANDEL THERAPEU...
|
Healthcare | 0.61% | 0.68% |
#23
1
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
405,837 | $4,236,938 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.51% | 0.80% |
#24
3
Prev: #21
|
1.2 |
—
|
no change | no change |
P
S
|
724,873 | $3,530,132 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
FIG
FIGMA INC
|
Technology | 0.00% | 0.07% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-22,165 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-25 of 25 holdings